Bliss GVS Pharma Limited (BOM:506197)
India flag India · Delayed Price · Currency is INR
603.40
-27.40 (-4.34%)
At close: Nov 6, 2026

Bliss GVS Pharma Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
10,0529,2718,0977,7027,5167,475
Revenue Growth
20.59%14.50%5.13%2.48%0.55%29.49%
Gross Profit
5,3494,7933,7923,6953,3803,444
Operating Income
1,6441,311977.581,242986.491,013
Net Income
1,3621,291842.99754.54708.59150.4
Earnings Per Share
12.6212.007.957.116.721.43
EPS Growth
25.28%50.94%11.81%5.80%369.93%-77.97%

Revenue by Geography

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '25 Mar '24 Mar '23 Mar '22
India
673.41530.18444.42391.62562.32
Outside India
8,4987,4887,2157,0836,817
Total
9,1728,0187,6597,4747,379

Cash & Debt

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
1,8861,8861,4131,404683.591,349
Total Debt
217.5217.5881.04998.41,0191,094
Net Cash (Debt)
1,6691,669532.41405.27-335.39255.5
Net Cash Growth
213.45%213.45%31.37%---
Net Cash Per Share
15.4715.515.023.82-3.182.43

Cash Flow & CapEx

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
-1,3871,0591,028343.141,355
Capital Expenditures
--568.31-762.86-283.29-937.99-740.03
Free Cash Flow
-818.87296.27744.87-594.86614.78
Free Cash Flow Growth
-176.39%-60.23%--12.09%

Margins

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
53.21%51.70%46.83%47.98%44.98%46.07%
Operating Margin
16.36%14.14%12.07%16.13%13.13%13.55%
Pretax Margin
20.09%20.45%15.52%15.17%14.11%7.25%
Profit Margin
13.55%13.93%10.41%9.80%9.43%2.01%
FCF Margin
-8.83%3.66%9.67%-7.92%8.22%

Dividends

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingNov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Dividend Per Share
2.0001.5000.5000.5000.5000.500
Dividend Per Share Growth
200.00%200.00%0%0%0%0%
Dividend Yield
0.33%0.70%0.43%0.44%0.70%0.65%

Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingNov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
47.8117.6614.6915.6310.4753.05
Forward PE
-6.576.576.576.576.57
P/FCF Ratio
78.3527.8541.8115.83-12.98
PS Ratio
6.382.461.531.530.991.07